To more clearly delineate the effects of anti-VEGF therapy from the natural disease course, comparison between treated and untreated DME and RVO patients would be ideal; however, withholding treatment poses significant ethical challenges given its established role in the management of vision-threatening macular edema. Here, VEGFA is linked to macular retinal edema.